Unprecedented in vivo activity of telacebec against Mycobacterium leprae.
<h4>Background</h4>New drugs targeting the electron transport chain (ETC) seem to be a promising advance in leprosy treatment. In this study, we evaluated the bactericidal activity of telacebec (TCB), a phase 2 drug candidate for tuberculosis, alongside known ETC-targeting antibiotics, b...
Saved in:
| Main Authors: | Aurélie Chauffour, Emmanuelle Cambau, Kevin Pethe, Nicolas Veziris, Alexandra Aubry |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-05-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0013076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacologic properties and inhibitory activity of 6-azasteroids against Mycobacterium leprae in vivo and in vitro
by: Thabatta L. S. A. Rosa, et al.
Published: (2025-07-01) -
Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148
by: Isabelle Bonnet, et al.
Published: (2025-07-01) -
Molecular Detection of Gene Mutation Related to Drug Resistance in Mycobacterium leprae
by: Saumya Shukla, et al.
Published: (2025-04-01) -
Advancing Mycobacterium leprae transmission research: Insights from the R2STOP fund
by: Marta Sólveig Palmeirim, et al.
Published: (2025-08-01) -
Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes.
by: Guillaume Tabouret, et al.
Published: (2010-10-01)